COVID-19 Impact on Global Subcutaneous Injection Immunoglobulin Market Insights, Forecast to 2026
Subcutaneous Injection Immunoglobulin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Subcutaneous Injection Immunoglobulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Subcutaneous Injection Immunoglobulin market is segmented into
The Subcutaneous Injection Immunoglobulin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Subcutaneous Injection Immunoglobulin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Subcutaneous Injection Immunoglobulin Market Share Analysis
Subcutaneous Injection Immunoglobulin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Subcutaneous Injection Immunoglobulin business, the date to enter into the Subcutaneous Injection Immunoglobulin market, Subcutaneous Injection Immunoglobulin product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Subcutaneous Injection Immunoglobulin market is segmented into
- 10% Purity
- 20% Purity
- Primary Immunodeficiency
- Secondary Immunodeficiency
- Others
The Subcutaneous Injection Immunoglobulin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Subcutaneous Injection Immunoglobulin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Subcutaneous Injection Immunoglobulin Market Share Analysis
Subcutaneous Injection Immunoglobulin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Subcutaneous Injection Immunoglobulin business, the date to enter into the Subcutaneous Injection Immunoglobulin market, Subcutaneous Injection Immunoglobulin product introduction, recent developments, etc.
The major vendors covered:
- Shire (Baxalta)
- Grifols
- CSL
- ...
1 STUDY COVERAGE
1.1 Subcutaneous Injection Immunoglobulin Product Introduction
1.2 Market Segments
1.3 Key Subcutaneous Injection Immunoglobulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Type
1.4.2 10% Purity
1.4.3 20% Purity
1.5 Market by Application
1.5.1 Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Application
1.5.2 Primary Immunodeficiency
1.5.3 Secondary Immunodeficiency
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Subcutaneous Injection Immunoglobulin Industry Impact
1.6.1 How the Covid-19 is Affecting the Subcutaneous Injection Immunoglobulin Industry
1.6.1.1 Subcutaneous Injection Immunoglobulin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Subcutaneous Injection Immunoglobulin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Subcutaneous Injection Immunoglobulin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Subcutaneous Injection Immunoglobulin Market Size Estimates and Forecasts
2.1.1 Global Subcutaneous Injection Immunoglobulin Revenue 2015-2026
2.1.2 Global Subcutaneous Injection Immunoglobulin Sales 2015-2026
2.2 Subcutaneous Injection Immunoglobulin Market Size by Region: 2020 Versus 2026
2.2.1 Global Subcutaneous Injection Immunoglobulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Subcutaneous Injection Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SUBCUTANEOUS INJECTION IMMUNOGLOBULIN COMPETITOR LANDSCAPE BY PLAYERS
3.1 Subcutaneous Injection Immunoglobulin Sales by Manufacturers
3.1.1 Subcutaneous Injection Immunoglobulin Sales by Manufacturers (2015-2020)
3.1.2 Subcutaneous Injection Immunoglobulin Sales Market Share by Manufacturers (2015-2020)
3.2 Subcutaneous Injection Immunoglobulin Revenue by Manufacturers
3.2.1 Subcutaneous Injection Immunoglobulin Revenue by Manufacturers (2015-2020)
3.2.2 Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Subcutaneous Injection Immunoglobulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Subcutaneous Injection Immunoglobulin Revenue in 2019
3.2.5 Global Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Subcutaneous Injection Immunoglobulin Price by Manufacturers
3.4 Subcutaneous Injection Immunoglobulin Manufacturing Base Distribution, Product Types
3.4.1 Subcutaneous Injection Immunoglobulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Subcutaneous Injection Immunoglobulin Product Type
3.4.3 Date of International Manufacturers Enter into Subcutaneous Injection Immunoglobulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Subcutaneous Injection Immunoglobulin Market Size by Type (2015-2020)
4.1.1 Global Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020)
4.1.2 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2015-2020)
4.1.3 Subcutaneous Injection Immunoglobulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Subcutaneous Injection Immunoglobulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Subcutaneous Injection Immunoglobulin Sales Forecast by Type (2021-2026)
4.2.2 Global Subcutaneous Injection Immunoglobulin Revenue Forecast by Type (2021-2026)
4.2.3 Subcutaneous Injection Immunoglobulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Subcutaneous Injection Immunoglobulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Subcutaneous Injection Immunoglobulin Market Size by Application (2015-2020)
5.1.1 Global Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020)
5.1.2 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2015-2020)
5.1.3 Subcutaneous Injection Immunoglobulin Price by Application (2015-2020)
5.2 Subcutaneous Injection Immunoglobulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Subcutaneous Injection Immunoglobulin Sales Forecast by Application (2021-2026)
5.2.2 Global Subcutaneous Injection Immunoglobulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Subcutaneous Injection Immunoglobulin Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Subcutaneous Injection Immunoglobulin by Country
6.1.1 North America Subcutaneous Injection Immunoglobulin Sales by Country
6.1.2 North America Subcutaneous Injection Immunoglobulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
6.3 North America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
7 EUROPE
7.1 Europe Subcutaneous Injection Immunoglobulin by Country
7.1.1 Europe Subcutaneous Injection Immunoglobulin Sales by Country
7.1.2 Europe Subcutaneous Injection Immunoglobulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
7.3 Europe Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Subcutaneous Injection Immunoglobulin by Region
8.1.1 Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region
8.1.2 Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
8.3 Asia Pacific Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Subcutaneous Injection Immunoglobulin by Country
9.1.1 Latin America Subcutaneous Injection Immunoglobulin Sales by Country
9.1.2 Latin America Subcutaneous Injection Immunoglobulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
9.3 Central & South America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Subcutaneous Injection Immunoglobulin by Country
10.1.1 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country
10.1.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
10.3 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Shire (Baxalta)
11.1.1 Shire (Baxalta) Corporation Information
11.1.2 Shire (Baxalta) Description, Business Overview and Total Revenue
11.1.3 Shire (Baxalta) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shire (Baxalta) Subcutaneous Injection Immunoglobulin Products Offered
11.1.5 Shire (Baxalta) Recent Development
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Description, Business Overview and Total Revenue
11.2.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Grifols Subcutaneous Injection Immunoglobulin Products Offered
11.2.5 Grifols Recent Development
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Description, Business Overview and Total Revenue
11.3.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Subcutaneous Injection Immunoglobulin Products Offered
11.3.5 CSL Recent Development
11.1 Shire (Baxalta)
11.1.1 Shire (Baxalta) Corporation Information
11.1.2 Shire (Baxalta) Description, Business Overview and Total Revenue
11.1.3 Shire (Baxalta) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shire (Baxalta) Subcutaneous Injection Immunoglobulin Products Offered
11.1.5 Shire (Baxalta) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Subcutaneous Injection Immunoglobulin Market Estimates and Projections by Region
12.1.1 Global Subcutaneous Injection Immunoglobulin Sales Forecast by Regions 2021-2026
12.1.2 Global Subcutaneous Injection Immunoglobulin Revenue Forecast by Regions 2021-2026
12.2 North America Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.2.1 North America: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.2.2 North America: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.2.3 North America: Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2021-2026)
12.3 Europe Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.3.1 Europe: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.3.2 Europe: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.3.3 Europe: Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Subcutaneous Injection Immunoglobulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.5.2 Latin America: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Subcutaneous Injection Immunoglobulin Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Subcutaneous Injection Immunoglobulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Subcutaneous Injection Immunoglobulin Product Introduction
1.2 Market Segments
1.3 Key Subcutaneous Injection Immunoglobulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Type
1.4.2 10% Purity
1.4.3 20% Purity
1.5 Market by Application
1.5.1 Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Application
1.5.2 Primary Immunodeficiency
1.5.3 Secondary Immunodeficiency
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Subcutaneous Injection Immunoglobulin Industry Impact
1.6.1 How the Covid-19 is Affecting the Subcutaneous Injection Immunoglobulin Industry
1.6.1.1 Subcutaneous Injection Immunoglobulin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Subcutaneous Injection Immunoglobulin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Subcutaneous Injection Immunoglobulin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Subcutaneous Injection Immunoglobulin Market Size Estimates and Forecasts
2.1.1 Global Subcutaneous Injection Immunoglobulin Revenue 2015-2026
2.1.2 Global Subcutaneous Injection Immunoglobulin Sales 2015-2026
2.2 Subcutaneous Injection Immunoglobulin Market Size by Region: 2020 Versus 2026
2.2.1 Global Subcutaneous Injection Immunoglobulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Subcutaneous Injection Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SUBCUTANEOUS INJECTION IMMUNOGLOBULIN COMPETITOR LANDSCAPE BY PLAYERS
3.1 Subcutaneous Injection Immunoglobulin Sales by Manufacturers
3.1.1 Subcutaneous Injection Immunoglobulin Sales by Manufacturers (2015-2020)
3.1.2 Subcutaneous Injection Immunoglobulin Sales Market Share by Manufacturers (2015-2020)
3.2 Subcutaneous Injection Immunoglobulin Revenue by Manufacturers
3.2.1 Subcutaneous Injection Immunoglobulin Revenue by Manufacturers (2015-2020)
3.2.2 Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Subcutaneous Injection Immunoglobulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Subcutaneous Injection Immunoglobulin Revenue in 2019
3.2.5 Global Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Subcutaneous Injection Immunoglobulin Price by Manufacturers
3.4 Subcutaneous Injection Immunoglobulin Manufacturing Base Distribution, Product Types
3.4.1 Subcutaneous Injection Immunoglobulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Subcutaneous Injection Immunoglobulin Product Type
3.4.3 Date of International Manufacturers Enter into Subcutaneous Injection Immunoglobulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Subcutaneous Injection Immunoglobulin Market Size by Type (2015-2020)
4.1.1 Global Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020)
4.1.2 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2015-2020)
4.1.3 Subcutaneous Injection Immunoglobulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Subcutaneous Injection Immunoglobulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Subcutaneous Injection Immunoglobulin Sales Forecast by Type (2021-2026)
4.2.2 Global Subcutaneous Injection Immunoglobulin Revenue Forecast by Type (2021-2026)
4.2.3 Subcutaneous Injection Immunoglobulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Subcutaneous Injection Immunoglobulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Subcutaneous Injection Immunoglobulin Market Size by Application (2015-2020)
5.1.1 Global Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020)
5.1.2 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2015-2020)
5.1.3 Subcutaneous Injection Immunoglobulin Price by Application (2015-2020)
5.2 Subcutaneous Injection Immunoglobulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Subcutaneous Injection Immunoglobulin Sales Forecast by Application (2021-2026)
5.2.2 Global Subcutaneous Injection Immunoglobulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Subcutaneous Injection Immunoglobulin Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Subcutaneous Injection Immunoglobulin by Country
6.1.1 North America Subcutaneous Injection Immunoglobulin Sales by Country
6.1.2 North America Subcutaneous Injection Immunoglobulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
6.3 North America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
7 EUROPE
7.1 Europe Subcutaneous Injection Immunoglobulin by Country
7.1.1 Europe Subcutaneous Injection Immunoglobulin Sales by Country
7.1.2 Europe Subcutaneous Injection Immunoglobulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
7.3 Europe Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Subcutaneous Injection Immunoglobulin by Region
8.1.1 Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region
8.1.2 Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
8.3 Asia Pacific Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Subcutaneous Injection Immunoglobulin by Country
9.1.1 Latin America Subcutaneous Injection Immunoglobulin Sales by Country
9.1.2 Latin America Subcutaneous Injection Immunoglobulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
9.3 Central & South America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Subcutaneous Injection Immunoglobulin by Country
10.1.1 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country
10.1.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Facts & Figures by Type
10.3 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Shire (Baxalta)
11.1.1 Shire (Baxalta) Corporation Information
11.1.2 Shire (Baxalta) Description, Business Overview and Total Revenue
11.1.3 Shire (Baxalta) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shire (Baxalta) Subcutaneous Injection Immunoglobulin Products Offered
11.1.5 Shire (Baxalta) Recent Development
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Description, Business Overview and Total Revenue
11.2.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Grifols Subcutaneous Injection Immunoglobulin Products Offered
11.2.5 Grifols Recent Development
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Description, Business Overview and Total Revenue
11.3.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Subcutaneous Injection Immunoglobulin Products Offered
11.3.5 CSL Recent Development
11.1 Shire (Baxalta)
11.1.1 Shire (Baxalta) Corporation Information
11.1.2 Shire (Baxalta) Description, Business Overview and Total Revenue
11.1.3 Shire (Baxalta) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shire (Baxalta) Subcutaneous Injection Immunoglobulin Products Offered
11.1.5 Shire (Baxalta) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Subcutaneous Injection Immunoglobulin Market Estimates and Projections by Region
12.1.1 Global Subcutaneous Injection Immunoglobulin Sales Forecast by Regions 2021-2026
12.1.2 Global Subcutaneous Injection Immunoglobulin Revenue Forecast by Regions 2021-2026
12.2 North America Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.2.1 North America: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.2.2 North America: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.2.3 North America: Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2021-2026)
12.3 Europe Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.3.1 Europe: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.3.2 Europe: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.3.3 Europe: Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Subcutaneous Injection Immunoglobulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.5.2 Latin America: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Subcutaneous Injection Immunoglobulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Subcutaneous Injection Immunoglobulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Subcutaneous Injection Immunoglobulin Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Subcutaneous Injection Immunoglobulin Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Subcutaneous Injection Immunoglobulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Subcutaneous Injection Immunoglobulin Market Segments
Table 2. Ranking of Global Top Subcutaneous Injection Immunoglobulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 10% Purity
Table 5. Major Manufacturers of 20% Purity
Table 6. COVID-19 Impact Global Market: (Four Subcutaneous Injection Immunoglobulin Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Subcutaneous Injection Immunoglobulin Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Subcutaneous Injection Immunoglobulin Players to Combat Covid-19 Impact
Table 11. Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Subcutaneous Injection Immunoglobulin Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Subcutaneous Injection Immunoglobulin Sales by Regions 2015-2020 (K Units)
Table 14. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 15. Global Subcutaneous Injection Immunoglobulin Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Subcutaneous Injection Immunoglobulin Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Subcutaneous Injection Immunoglobulin Sales Share by Manufacturers (2015-2020)
Table 18. Global Subcutaneous Injection Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Subcutaneous Injection Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Injection Immunoglobulin as of 2019)
Table 20. Subcutaneous Injection Immunoglobulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Subcutaneous Injection Immunoglobulin Price (2015-2020) (USD/Unit)
Table 23. Subcutaneous Injection Immunoglobulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Subcutaneous Injection Immunoglobulin Product Type
Table 25. Date of International Manufacturers Enter into Subcutaneous Injection Immunoglobulin Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 28. Global Subcutaneous Injection Immunoglobulin Sales Share by Type (2015-2020)
Table 29. Global Subcutaneous Injection Immunoglobulin Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Subcutaneous Injection Immunoglobulin Revenue Share by Type (2015-2020)
Table 31. Subcutaneous Injection Immunoglobulin Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 33. Global Subcutaneous Injection Immunoglobulin Sales Share by Application (2015-2020)
Table 34. North America Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 35. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 36. North America Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 38. North America Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 39. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 40. North America Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 41. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 42. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 43. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 44. Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 46. Europe Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 47. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 48. Europe Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 49. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 58. Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 59. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 62. Latin America Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 63. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 64. Latin America Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 65. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 74. Shire (Baxalta) Corporation Information
Table 75. Shire (Baxalta) Description and Major Businesses
Table 76. Shire (Baxalta) Subcutaneous Injection Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Shire (Baxalta) Product
Table 78. Shire (Baxalta) Recent Development
Table 79. Grifols Corporation Information
Table 80. Grifols Description and Major Businesses
Table 81. Grifols Subcutaneous Injection Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Grifols Product
Table 83. Grifols Recent Development
Table 84. CSL Corporation Information
Table 85. CSL Description and Major Businesses
Table 86. CSL Subcutaneous Injection Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. CSL Product
Table 88. CSL Recent Development
Table 89. Global Subcutaneous Injection Immunoglobulin Sales Forecast by Regions (2021-2026) (K Units)
Table 90. Global Subcutaneous Injection Immunoglobulin Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Subcutaneous Injection Immunoglobulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Subcutaneous Injection Immunoglobulin Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 94. North America: Subcutaneous Injection Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 96. Europe: Subcutaneous Injection Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Subcutaneous Injection Immunoglobulin Sales Forecast by Region (2021-2026) (K Units)
Table 98. Asia Pacific: Subcutaneous Injection Immunoglobulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 100. Latin America: Subcutaneous Injection Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 102. Middle East and Africa: Subcutaneous Injection Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Subcutaneous Injection Immunoglobulin Players
Table 107. Subcutaneous Injection Immunoglobulin Customers List
Table 108. Subcutaneous Injection Immunoglobulin Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 1. Subcutaneous Injection Immunoglobulin Market Segments
Table 2. Ranking of Global Top Subcutaneous Injection Immunoglobulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 10% Purity
Table 5. Major Manufacturers of 20% Purity
Table 6. COVID-19 Impact Global Market: (Four Subcutaneous Injection Immunoglobulin Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Subcutaneous Injection Immunoglobulin Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Subcutaneous Injection Immunoglobulin Players to Combat Covid-19 Impact
Table 11. Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Subcutaneous Injection Immunoglobulin Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Subcutaneous Injection Immunoglobulin Sales by Regions 2015-2020 (K Units)
Table 14. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 15. Global Subcutaneous Injection Immunoglobulin Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Subcutaneous Injection Immunoglobulin Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Subcutaneous Injection Immunoglobulin Sales Share by Manufacturers (2015-2020)
Table 18. Global Subcutaneous Injection Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Subcutaneous Injection Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Injection Immunoglobulin as of 2019)
Table 20. Subcutaneous Injection Immunoglobulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Subcutaneous Injection Immunoglobulin Price (2015-2020) (USD/Unit)
Table 23. Subcutaneous Injection Immunoglobulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Subcutaneous Injection Immunoglobulin Product Type
Table 25. Date of International Manufacturers Enter into Subcutaneous Injection Immunoglobulin Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 28. Global Subcutaneous Injection Immunoglobulin Sales Share by Type (2015-2020)
Table 29. Global Subcutaneous Injection Immunoglobulin Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Subcutaneous Injection Immunoglobulin Revenue Share by Type (2015-2020)
Table 31. Subcutaneous Injection Immunoglobulin Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 33. Global Subcutaneous Injection Immunoglobulin Sales Share by Application (2015-2020)
Table 34. North America Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 35. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 36. North America Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 38. North America Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 39. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 40. North America Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 41. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 42. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 43. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 44. Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 46. Europe Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 47. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 48. Europe Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 49. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 58. Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 59. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 62. Latin America Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 63. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 64. Latin America Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 65. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Table 74. Shire (Baxalta) Corporation Information
Table 75. Shire (Baxalta) Description and Major Businesses
Table 76. Shire (Baxalta) Subcutaneous Injection Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Shire (Baxalta) Product
Table 78. Shire (Baxalta) Recent Development
Table 79. Grifols Corporation Information
Table 80. Grifols Description and Major Businesses
Table 81. Grifols Subcutaneous Injection Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Grifols Product
Table 83. Grifols Recent Development
Table 84. CSL Corporation Information
Table 85. CSL Description and Major Businesses
Table 86. CSL Subcutaneous Injection Immunoglobulin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. CSL Product
Table 88. CSL Recent Development
Table 89. Global Subcutaneous Injection Immunoglobulin Sales Forecast by Regions (2021-2026) (K Units)
Table 90. Global Subcutaneous Injection Immunoglobulin Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Subcutaneous Injection Immunoglobulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Subcutaneous Injection Immunoglobulin Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 94. North America: Subcutaneous Injection Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 96. Europe: Subcutaneous Injection Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Subcutaneous Injection Immunoglobulin Sales Forecast by Region (2021-2026) (K Units)
Table 98. Asia Pacific: Subcutaneous Injection Immunoglobulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 100. Latin America: Subcutaneous Injection Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Subcutaneous Injection Immunoglobulin Sales Forecast by Country (2021-2026) (K Units)
Table 102. Middle East and Africa: Subcutaneous Injection Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Subcutaneous Injection Immunoglobulin Players
Table 107. Subcutaneous Injection Immunoglobulin Customers List
Table 108. Subcutaneous Injection Immunoglobulin Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Subcutaneous Injection Immunoglobulin Product Picture
Figure 2. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type in 2020 & 2026
Figure 3. 10% Purity Product Picture
Figure 4. 20% Purity Product Picture
Figure 5. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application in 2020 & 2026
Figure 6. Primary Immunodeficiency
Figure 7. Secondary Immunodeficiency
Figure 8. Others
Figure 9. Subcutaneous Injection Immunoglobulin Report Years Considered
Figure 10. Global Subcutaneous Injection Immunoglobulin Market Size 2015-2026 (US$ Million)
Figure 11. Global Subcutaneous Injection Immunoglobulin Sales 2015-2026 (K Units)
Figure 12. Global Subcutaneous Injection Immunoglobulin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Figure 14. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region in 2019
Figure 15. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Figure 16. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region in 2019
Figure 17. Global Subcutaneous Injection Immunoglobulin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Subcutaneous Injection Immunoglobulin Revenue in 2019
Figure 19. Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Figure 21. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type in 2019
Figure 22. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2015-2020)
Figure 23. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type in 2019
Figure 24. Global Subcutaneous Injection Immunoglobulin Market Share by Price Range (2015-2020)
Figure 25. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Figure 26. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application in 2019
Figure 27. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2015-2020)
Figure 28. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application in 2019
Figure 29. North America Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 32. North America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 33. U.S. Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 38. North America Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 39. Europe Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 42. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 43. Germany Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 54. Europe Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 55. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Market Share by Region in 2019
Figure 59. China Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 82. Asia Pacific Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 83. Latin America Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 86. Latin America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 87. Mexico Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 94. Latin America Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 95. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 99. Turkey Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 106. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 107. Shire (Baxalta) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. North America Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
Figure 1. Subcutaneous Injection Immunoglobulin Product Picture
Figure 2. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type in 2020 & 2026
Figure 3. 10% Purity Product Picture
Figure 4. 20% Purity Product Picture
Figure 5. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application in 2020 & 2026
Figure 6. Primary Immunodeficiency
Figure 7. Secondary Immunodeficiency
Figure 8. Others
Figure 9. Subcutaneous Injection Immunoglobulin Report Years Considered
Figure 10. Global Subcutaneous Injection Immunoglobulin Market Size 2015-2026 (US$ Million)
Figure 11. Global Subcutaneous Injection Immunoglobulin Sales 2015-2026 (K Units)
Figure 12. Global Subcutaneous Injection Immunoglobulin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2015-2020)
Figure 14. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region in 2019
Figure 15. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2015-2020)
Figure 16. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region in 2019
Figure 17. Global Subcutaneous Injection Immunoglobulin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Subcutaneous Injection Immunoglobulin Revenue in 2019
Figure 19. Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020)
Figure 21. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type in 2019
Figure 22. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2015-2020)
Figure 23. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type in 2019
Figure 24. Global Subcutaneous Injection Immunoglobulin Market Share by Price Range (2015-2020)
Figure 25. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020)
Figure 26. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application in 2019
Figure 27. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2015-2020)
Figure 28. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application in 2019
Figure 29. North America Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 32. North America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 33. U.S. Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 38. North America Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 39. Europe Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 42. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 43. Germany Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 54. Europe Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 55. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Market Share by Region in 2019
Figure 59. China Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 82. Asia Pacific Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 83. Latin America Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 86. Latin America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 87. Mexico Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 94. Latin America Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 95. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019
Figure 99. Turkey Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Share by Type in 2019
Figure 106. Middle East and Africa Subcutaneous Injection Immunoglobulin Market Share by Application in 2019
Figure 107. Shire (Baxalta) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. North America Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
